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Abstract
The role of interferon-gamma (IFNγ) in antiviral innate immune responses during acute alphavirus infection is not well defined. We
examined the contribution of IFNγ to the protection of adult mice from Sindbis virus (SB)-induced disease by comparing subcutaneous
infection of mice lacking receptors for either IFNα/β (A129), IFNγ (G129) or both (AG129) to normal mice (WT129). While neither G129
nor WT129 mice exhibited clinical signs of disease, infection of A129 or AG129 mice was fatal with AG129 mice succumbing more rapidly.
Furthermore, AG129 mice developed signs of viral hemorrhagic fever (VHF), including extensive hepatocellular damage, inflammatory
infiltrates in multiple organs and vascular leakage, which were significantly delayed and/or partially ameliorated during fatal A129 infections.
We conclude that: (i) IFNα/β is the primary mediator of innate immunity to SB infection, however; (ii) IFNγ is directly antiviral in vivo,
acting before the adaptive immune response appears and; (iii) development of VHF may involve viral suppression of both IFNα/β and IFNγ
responses.
© 2007 Published by Elsevier Inc.Keywords: Alphavirus; Sindbis; Interferon; Viral hemorrhagic feverIntroduction
Among the mosquito-borne viruses in the Alphavirus genus,
family Togaviridae, are a number of significant human patho-
gens that cause explosive outbreaks of febrile illness associated
with polyarthritis and occasional hemorrhagic manifestations of
varying severity (Enserink, 2006; Laine et al., 2004; Posey et al.,
2005). These viruses include chikungunya, Ross River, o'nyong
nyong and the Sindbis group viruses, Karelian fever and Okelbo.
Although these viruses are causative agents of emerging infect-
ious disease, their biology is poorly understood and neither⁎ Corresponding author. Department of Microbiology and Immunology,
Louisiana State University Health Sciences Center, 2-347A Medical School
Building B, 1501 Kings Hwy, Shreveport, LA 71130-3932, USA. Fax: +1 318
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doi:10.1016/j.virol.2007.06.039effective therapeutics, nor licensed vaccines are available for
protection of humans.
In nature, the prototypic alphavirus, Sindbis virus strain
AR339 (SB), is maintained by mosquito-vectored transmission
between avian reservoir hosts and, unlike several closely related
alphaviruses, it is not believed to be a significant human patho-
gen (Griffin, 2001). Using this non-pathogenic virus to probe the
host's immune response, we seek to elucidate virulence
mechanisms employed by arboviral pathogens and explore the
premise that virulent arboviruses antagonize and/or evade
antiviral mechanisms to which SB is sensitive. When cDNA
clone-derived, wild-type SB virus strain TR339 (Klimstra et al.,
1998; McKnight et al., 1996) is administered to newborn mice
by subcutaneous inoculation, mimicking the bite of an infected
mosquito, a rapidly fatal infection ensues reminiscent of sys-
temic inflammatory response syndrome (SIRS; Conti et al.,
2004) with uncontrolled pathogen replication and systemic
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interferon gamma (IFNγ), tumor necrosis factor alpha (TNFα)
and interleukin (IL)-6 (Klimstra et al., 1999). The absence of
encephalomyelitis in this infection model (Klimstra et al., 1999)
is consistent with febrile disease manifestations of arthritogenic
alphaviruses in young humans.
Similar to other SB strains (Griffin, 1976; Johnson et al.,
1972; Trgovcich et al., 1999), the severity of TR339-induced
disease is intriguingly age-dependent (Ryman et al., 2007b),
such that TR339 infection of an adult mouse is swiftly
controlled by the host's immune system with little or no
pathologic damage and induction of long-lasting, protective
immunity (Ryman et al., 2000). Although a variety of host-
encoded factors have been demonstrated to influence SB
virulence and disease (e.g., Griffin et al., 1983; Johnston et al.,
2001; Levine et al., 1996; Lewis et al., 1999; Liang et al., 1998),
type I IFN has emerged as the critical mediator of defense in
naive animals against infection by SB (Byrnes et al., 2000; Gil
et al., 2001; Labrada et al., 2002; Ryman et al., 2000, 2002) and,
to a lesser extent, other alphaviruses (Muller et al., 1994; White
et al., 2001; Aguilar et al., 2005). In mice which lack a subunit
of the IFNα/β receptor (A129) and are, therefore, defective in
IFNα/β-mediated signaling and IFNα/β-stimulated gene (ISG)
upregulation, normally benign TR339 infection becomes
rapidly fatal (Ryman et al., 2000), highlighting the pivotal
protective role of early IFNα/β responses and the necessity for
antagonism/evasion by the pathogen. Absence of IFNα/β
activity allows extensive replication in dendritic cells (DCs)
which migrate to the lymph nodes draining the inoculation site
(DLN) followed by viremic dissemination to myeloid-lineage
cells in spleen, liver and other tissues. Infection of these cells
correlates with the dysregulated induction of a hyperinflamma-
tory cytokine cascade and rapid mortality. However, if A129
mice are “immunized” by infection with attenuated, cell culture-
adapted, heparan sulfate (HS)-binding SB strains (Byrnes et al.,
2000; Ryman et al., 2000), subsequent challenge with virulent
virus is subclinical, from which we infer that acquired immune
response mediators remain operational.
Whereas the ability to produce type I IFN is shared by most
cell types, type II IFN (IFNγ) is primarily secreted by activated
natural killer (NK) cells, TH1-biased CD4
+ T cells, CD8+ T and
NKT cells, with a lesser contribution from DCs and macro-
phages. IFNγmediates immunoregulatory effects on both innate
and adaptive immune responses by inducing antiviral effectors,
activating macrophages and microglia and upregulating antigen
presentation machinery. T cells serve to protect non-renewable
cells in the central nervous system (CNS) from several neuro-
tropic viruses (Chesler and Reiss, 2002; Keogh et al., 2003) via
IFNγ-dependent, non-cytolytic downregulation of viral replica-
tion. Furthermore, IFNγ controls levels of hepatitis B virus
replication in the liver and mediates clearance by T cells
(Guidotti and Chisari, 1999; Guidotti et al., 2002). Intriguingly,
IFNγ has recently been implicated in the control of acute
infection by other mosquito-borne viruses, dengue and West
Nile viruses (Shresta et al., 2004; Shrestha et al., 2006) and acts
in concert with antibody to prevent reactivation of SB infection
in the CNS after initial clearance (Burdeinick-Kerr et al., 2007).Here, we have evaluated the role of IFNγ in amelioration of
acute SB-induced disease following subcutaneous inoculation,
encouraged by interesting, but conflicting observations. We
found previously that PKR/RNase L-dependent and indepen-
dent antiviral activities against SB were potently induced by
IFNα/β-mediated or IFNγ-mediated priming of DCs, indepen-
dently of one another (Ryman et al., 2002). Paradoxically, high-
level induction of IFNγ in infected A129 mice appeared to
provide little protective effect against lethal disease (Ryman et
al., 2000), although Gil et al. demonstrated that fatal infection of
AG129 mice by a cell culture-adapted, attenuated SB strain
required 100-fold less inoculum than A129 mice (Gil et al.,
2001). To determine whether or not IFNγ has antiviral activity
in vivo in the presence or absence of the type I IFN response,
mice lacking either the IFNγ receptor (G129), the IFNα/β
receptor (A129) or both receptors (AG129) were infected
subcutaneously with TR339 and the pathogenesis of infection
was examined.
Absence of IFNγ activity alone resulted in a minor, but not
consistently significant, increase in viral burden early during the
course of infection; however, both WT129 and G129 mice were
protected from clinical disease signs by a functioning IFNα/β
response. Mice with combined deficiency in IFNα/β and IFNγ
responses exhibited an even more rapid spread of virus infection
and more intense hyperinflammatory disease and rapid death as
compared with deficiency in the IFNα/β response alone.
Moribund AG129 mice exhibited severe pathologies of liver
and lymphoid tissues and evidence of vasculopathy, typically
associated with VHF in humans (Bray, 2005). These findings
are striking in that an avirulent virus can be converted to a virus
that causes VHF manifestations by the combined elimination of
IFN responses. This result may implicate antagonism of or
resistance to IFNγ, as well as IFNα/β, as underlying causes of
VHF for some viruses and may provide a mouse model system




Baby hamster kidney (BHK-21: ATCC CCL-10) and L929
murine fibrosarcoma cell lines were maintained in alpha
minimal essential medium (αMEM), supplemented with 10%
donor calf serum (DCS), 2.9 mg/ml tryptose phosphate,
0.29 mg/ml L-glutamine, 100 U/ml penicillin and 0.05 mg/ml
streptomycin (37 °C; 5% CO2).
Mice
Mice with null mutations in the IFNα/β receptor (A129), the
IFNγ receptor (G129) or both the IFNα/β and the IFNγ
receptors (AG129) and congenic 129/Sv/Pas mice (WT129)
were bred and housed in the Animal Resource Center at
Louisiana State University Health Sciences Center (Shreveport,
LA) under specific pathogen-free conditions. All procedures
were carried out in accordance with the guidelines of the
275K.D. Ryman et al. / Virology 368 (2007) 273–285LSUHSC-S Institutional Animal Care and Use Committee. Mice
were used at 6 to 8 weeks of age, and all experiments were
performed in the Biosafety Level 2 animal facility at LSUHSC-S.
cDNA clones and viruses
Construction of cDNA clones for the consensus wild-type SB
virus strain TR339 (Klimstra et al., 1998) and neurovirulent
39H55K70 (Ryman et al., 2007a) have been described
previously. Capped, infectious viral RNAs were generated by
in vitro transcription (mMessage mMachine, Ambion) from
XhoI-linearized DNA templates and electroporated into BHK-21
cells. Virus particles were harvested from the supernatant 18–
20 h after electroporation, clarified by centrifugation and stored
at −80 °C in single-use aliquots. Virus stocks were titered by
standard BHK-21 cell plaque assay and titers were expressed as
plaque forming units (pfu)/ml.
Mortality studies
Virus inocula containing 100 pfu of TR339 in a 10 μl volume
(1×104 pfu/ml) were administered subcutaneously in the right
rear footpad using a 27-gauge needle and 100 μl gas-tight
Hamilton syringe. Mock-infected mice received 10 μl PBS–1%
DCS by the same route. Virus-infected and corresponding mock-
infectedmice were observed at 12 h intervals, scored for degree of
sickness and weighed at 24 h intervals where appropriate. Ave-
rage survival times (AST) and percent mortality were calculated.
Pathogenesis studies
At predetermined intervals post-infection (p.i.), groups of three
mice per treatment were sacrificed under isoflurane anesthesia and
blood was collected by cardiac puncture. Serum was separated
from whole blood using microtainer tubes (Becton-Dickinson)
and stored in single-use aliquots at −80 °C. Mice were perfused
with PBS–1% DCS for 10 min at 7 ml/min to flush blood-borne
virus. Tissues were harvested into preweighed Kontes tubes,
homogenized in PBS–1% DCS and clarified by centrifugation
(13,000×g, 15 min, 4 °C). Supernatants were assayed for virus by
standard plaque assay, expressed as pfu/ml or g.
Histopathology
Three mice per treatment were randomly selected. Under
anesthesia, each mouse was perfused with 4% paraformaldehyde
(PFA) in PBS (pH 7.4) for 10–15 min, fixed in 4% PFA (pH 7.4)
for 1 week then decalcified in 4% PFA, 8% EDTA (pH 6.8, 4 °C).
Paraffin-embedded, hematoxylin and eosin (H&E)-stained sec-
tions were viewed by light microscopy using a Nikon TE300
invertedmicroscope and analyzed usingACT-1 imaging software.
Cytokine and chemokine analyses
Serum IFNα/βwasmeasured by standard biological assay on
L929 cells as described previously (Trgovcich et al., 1996), using
a commercially prepared IFNα/β standard (Access Biomole-cular) and encephalomyocarditis virus (EMCV) as the indicator
virus. Endpoint was defined as the dilution of IFNα/β required to
protect 50%of the cells fromEMCV-induced cpe and the level of
IFNα/β was expressed as international units (IU)/ml or g. For
measurement of other cytokines and chemokines, serum was
diluted 1:4 in serum diluent (BioRad) and analyzed by X-Plex
Cytokine Bead Array (BioPLex, BioRad) according to manufac-
turer's instructions. Briefly, diluted serum was incubated with
beads conjugated to cytokine specific antibodies. A cytokine
specific biotinylated secondary detection antibody and strepta-
vidin-PE were used to detect bead-bound cytokine molecules.
Data were collected using the flow cytometry-based BioPlex
Suspension Array and BioPlex Manager software (BioRad).
BioPlex Manager software was used to calculate cytokine
concentrations based on a standard curve generated using
recombinant cytokine standards.
Vascular leakage
At 30 and 60 h p.i., a 30 mg/kg dose of fluorescein
isothiocyanate-conjugated bovine serum albumin (FITC-BSA)
was delivered intravenously to TR339-infected and mock-
infected mice. FITC-BSA was allowed to circulate for 30 min
before mice were sacrificed and serum, as well as liver, spleen,
thymus, lung and brain tissue samples were collected. FITC
fluorescence in the serum was measured (PolarStar Optima,
BMGLabtech) to verify equal delivery of the FITC-BSA. Tissue
samples were frozen in OCT embedding compound over liquid
nitrogen and 10 μm sections were cut. Tissue sections were
examined using a Nikon TE300 inverted fluorescence micro-
scope and analyzed using ACT-1 imaging software.
Blood chemistry analyses
Serum concentrations of aspartate aminotransferase (AST)
and alanine aminotransferase (ALT) were measured using
Infinity AST and Infinity ALT Reagents (Thermo Electron
Corp.), respectively. Briefly, 200 μl of reagent was added to
20 μl of undiluted serum and absorbance was measured at
340 nm every 30 s for 3 min to determine the rate of change.
Serum AST and ALT concentrations were calculated based on a
standard curve generated using the “abnormal serum” control
with known AST and ALT concentrations.
Results
TR339-induced disease in the absence of IFNα/β and/or IFNγ
responses
Regardless of the inoculum dose, subcutaneous administra-
tion of wild-type SB strain TR339 to normal, adult mice results
in an asymptomatic, self-limiting infection and induction of a
protective immune response (Ryman et al., 2000). Here, we
have evaluated the role of IFNγ in amelioration of acute SB-
induced disease in the presence or absence of IFNα/β-mediated
antiviral activity (Fig. 1A). When adult mice lacking the IFNγ
receptor (G129) were inoculated subcutaneously with 100 pfu
Fig. 1. Susceptibility of mice with compromised interferon responses to infection with wild-type SB strain TR339. Mice were subcutaneously inoculated with 100 pfu
of TR339, monitored for 3 weeks and euthanized in extremis. Kaplan–Meier survival curves are shown comparing infections of (A) WT129, G129 (indistinguishable;
dotted line), A129 (solid line) and AG129 (dashed line) mice; or (B) WT129 (dotted line) and STAT1−/− (solid line) mice. For each mouse strain, n≥8 animals and
data are representative of at least two experiments.
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disease than congenic WT129 animals. Although infection
remained subclinical throughout the 3-week observation period,
virus replication in WT129 and G129 mice was evidenced by
elicitation of a high-titer serum antibody response and
protection from intracerebral challenge with a mouse-adapted,
neurovirulent SB strain, 39H55K70 (data not shown; Ryman et
al., 2007a). Moreover, naive WT129 and G129 mice did not
differ significantly in their susceptibility to 39H55K70-induced
disease following either subcutaneous or intracerebral inocula-
tion (data not shown). We conclude that, in the presence of a
functional IFNα/β system, SB infection was resolved with no
overt manifestations, independently of IFNγ activity.
In contrast, as we have described previously (Ryman et al.,
2000), adult mice lacking the IFNα/β receptor (A129) were
extremely susceptible to TR339 infection, succumbing to fatal
disease within 3 days of inoculation (Fig. 1A; 63.0±0.6 h p.i.).
However, the survival time of TR339-infected mice lacking
both the IFNα/β and IFNγ receptors (AG129) was significantly
shortened (36.0±0.0 h p.i.; Fig. 1A). In both A129 and AG129
animals, the onset of clinical disease signs, including ruffled fur,
hunched posture and weight loss, occurred abruptly, after which
animals rapidly deteriorated, becoming ataxic and developing
respiratory difficulties. However, disease onset occurred earlier
in the absence of IFNγ activity, with morbidity observed within
24 h p.i. and death following approximately 12 h later. These
observations suggest that, although the antiviral activity of
IFNγ is subordinate to that of IFNα/β in protecting normal
mice from fatal SB infection, nonetheless IFNγ plays a
significant protective role in the absence of IFNα/β. Since
mice lacking the IFNα/β receptor die within 3 days of exposure
to virus, it is unlikely that acquired immune responses are
involved, suggesting a more direct and non-specific antiviral
effect of IFNγ.
In previous studies with an attenuated, cell culture-adapted
SB strain, TEQ12, STAT1−/− mice were shown to be more
susceptible to fatality than WT129 controls, but significantly
more resistant than A129 or AG129 mice (Gil et al., 2001),
revealing the existence of STAT1-independent protective
effects. In our studies using wild-type SB strain TR339, infectedSTAT1−/− mice developed disease and died with similar kinetics
to A129 mice (Fig. 1B). Since both IFNα/β and IFNγ-mediated
antiviral effects partially depend upon STAT1 signaling, this
result suggests that protection of adult mice against wild-type SB
infection occurs via a combination of STAT1-dependent and
STAT1-independent mechanism(s). This is in keeping with in
vitro observations made by Shresta et al. (2005).
TR339 replication in the absence of IFNα/β and IFNγ antiviral
activity
IFNγ is induced in TR339-infected A129 mice (Ryman et
al., 2000) and elicits robust, IFNα/β-independent antiviral
activity against SB in vitro (Ryman et al., 2002). Therefore, we
reasoned that IFNγ may play a role in mediating early virus
restriction in vivo, particularly in the absence of the type I IFN
response. Therefore, we investigated the ability of TR339 to
replicate and disseminate after subcutaneous inoculation by
titration of infectious virus from mouse tissues, primarily
comparing WT129 to G129 and A129 to AG129 mice (Fig. 2),
to elucidate the role of IFNγ in the presence or absence of
IFNα/β responses, respectively.
Consistent with morbidity/mortality data, TR339 replication
and dissemination were similarly restricted in WT129 and G129
mice, not exceeding 104 pfu/ml or g in any tissue at any time p.i.
(Fig. 2). Early replication was observed in the popliteal lymph
node which drains the inoculation site (draining lymph node
[DLN]; Fig. 2A), followed by the seeding of a serum viremia
(Fig. 2B) and low level, disseminated replication, in tissues
including the spleen (Fig. 2C) and liver (Fig. 2D). Virus titers
tended to be higher in G129 mice than in their WT129
counterparts, but the differences were not consistently statisti-
cally significant and were apparently below the threshold level
necessary to cause clinical signs of disease. Although infectious
virus remained detectable 72 h p.i., the downward trend sug-
gested that clearance was underway in the presence or absence of
the IFNγ receptor.
To assess the role of IFNγ in the absence of the protective
type I IFN response, we compared viral replication and spread in
tissues of A129 and AG129 mice. As demonstrated previously,
Fig. 3. Induction kinetics of IFNα/β and IFNγ following TR339 infection.
WT129 (black square), G129 (white square), A129 (black circle) and AG129
(white circle) mice were inoculated subcutaneously with 100 pfu TR339 and
serum was collected at intervals p.i. Serum levels of IFNα/β (A) and IFNγ (B)
were measured by bioassay or Bioplex Bead Assay, respectively. Values
represent the geometric mean cytokine level (log10 IU/ml of IFNα/β or pg/ml of
IFNγ) for three mice and are shown±SD.
Fig. 2. Isolated and combined effects of IFNα/β and IFNγ on the replication and dissemination of SB strain TR339 in vivo. WT129 (black square), G129 (white
square), A129 (black circle) and AG129 (white circle) mice were inoculated subcutaneously in one rear footpad with 100 pfu TR339 and sacrificed at various times p.i.
Virus titers from draining lymph node (DLN; A), serum (B), spleen (C), liver (D), kidney (E) and brain (F) were determined. Values represent the geometric mean virus
titer (log10 pfu/ml or g) for three mice, determined on BHK cells, and are shown±standard deviation (SD).
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TR339 infection and disease, compared to IFN-competent
WT129 controls, correlated with a tremendous increase in virus
replication, frequently in tissues not normally considered
particularly susceptible to infection, such as spleen and liver
(Ryman et al., 2000; Fig. 2). Early replication kinetics did not
differ substantially from A129 infection in the absence of both
IFNα/β and IFNγ receptors. However, by 24 h p.i. splenic
(Fig. 2C) and particularly hepatic (Fig. 2D) viral loads in
AG129 mice escalated dramatically compared with A129
mouse tissues, reaching 10- to 100-fold higher titers. Beyond
24 h p.i., virus titers continued to rise both in the presence and
absence of IFNγ until the time of death, with no evidence of
clearance. These findings implied a tissue-specific role for
IFNγ-mediated protective effects, particularly evident in the
hepatic compartment.
Induction of IFNα/β and IFNγ in TR339-infected mice
Since both IFNγ and IFNα/β appear to have antiviral
activity in SB-infected mice, we determined the kinetics of their
induction (Fig. 3). Although induced IFNα/β was not
detectable in the serum of WT129 mice until 60 h p.i., we
detected low, but significant, levels in G129 mice by 12 h p.i.
(Fig. 3A). As expected, uncontrolled induction of IFNα/β was
observed in the absence of the IFNα/β receptor in the presence
or absence of the IFNγ receptor. We infer that, in WT129 and
G129 mice, the virus infection is so rapidly and efficiently
controlled by low-level, local IFNα/β induction or a pre-
existing IFNα/β-mediated antiviral state that IFNα/β rarely
278 K.D. Ryman et al. / Virology 368 (2007) 273–285becomes detectable in serum. The fact that little IFNγ induction
was observed in these animals (Fig. 3B) may, therefore, be
explained by the prior IFNα/β-mediated restriction of virus
replication.
In mice lacking IFNα/β-mediated control of early virus
replication, antiviral activity of IFNγ is apparent, particularly in
the liver, by 24 h p.i. (Fig. 2D). In keeping with this observation,
the antiviral effect was preceded by systemic release of IFNγ in
infected A129 mice between 12 and 18 h p.i. (Fig. 3B). Levels of
IFNγ became extremely elevated in AG129 mice (in excess of
20 ng/ml), presumably due to a combination of high virus titer
and lack of feedback inhibition in the absence of the IFNγ
receptor. Thus, IFNγ-mediated control of virus infection and
spread beyond the inoculation site may be delayed by the
necessity for de novo induction and synthesis after virus
infection, compared to IFNα/β which is synthesized at low
levels in the naive host and released extremely rapidly upon
infection (Taniguchi and Takaoka, 2001). In support of this
hypothesis and demonstrating direct antiviral activity of IFNγ,
the onset and progression of clinical signs of disease were
delayed and the average survival time was significantly
extended (22±10.9 h extension of survival; pb0.003) overFig. 4. Cytokine and chemokine levels in serum from TR339-infected and mock-infe
AG129 (white circle) mice were inoculated subcutaneously with 100 pfu TR339 or w
of proinflammatory cytokines were determined by Bioplex Bead Assay, as follows:
(G) MIP-1β; (H) TNFα; and (I) IL-6. Values represent the mean cytokine level fovehicle-treated controls, when A129 mice were pretreated with
2 μg of recombinant IFNγ, 6 h before infection with TR339.
Inflammatory chemokine/cytokine induction profiles during
TR339 infection
We have previously observed a strong correlation between
enhanced in vivo replicative potential of TR339, hyperinflam-
matory cytokine induction and virulence defined as shorter
survival time and increased mortality rate (Klimstra et al., 1998,
1999; Ryman et al., 2000, 2007b). Here, serum cytokine profiles
were determined to assess whether a pronounced systemic
response might be contributing to the severity and etiology of
disease in the combined absence of IFNγ and IFNα/β activity
(Fig. 4). Minimal elevation of serum cytokines over mock-
infected controls was detectable in infected WT129 or G129
mice. In the absence of IFNα/β antiviral activity (A129), a
significantly elevated cytokine profile was evident, confirming
and extending our previous description of an SIRS-like disease
in these animals (Ryman et al., 2000). In AG129 mice, IL-12
p70, RANTES, IL-1α, IL-1β, MCP-1, MIP-1α, MIP-1β, TNFα
and IL-6 levels rose between 24 and 36 h p.i. to significantlycted mice. WT129 (black square), G129 (white square), A129 (black circle) and
ith PBS (Mk), and the serum was harvested at various times p.i. The serum levels
(A) IL-12 p40; (B) IL-1α; (C) IL-1β; (D) MCP-1; (E) RANTES; (F) MIP-1α;
r three mice and are shown±SD.
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between 36 and 42 h p.i., when AG129 mice became moribund,
a tremendous release of proinflammatory mediators MCP-1,
MIP-1α, MIP-1β, TNFα and IL-6 was detected, coincident with
peak virus replication titers. Interestingly, concurrent elevation
of the anti-inflammatory cytokine IL-10 was also observed in
moribund AG129 mice (data not shown), suggesting that the
immune mediators were dysregulated. This is in striking contrast
to our previous findings that systemic proinflammatory cytokine
induction during TR339 infection of A129 mice returned to
baseline levels by 72 h p.i. when these mice were moribund
(Ryman et al., 2000).
The severity of dengue virus infection in AG129 mice was
shown to be significantly ameliorated by neutralization of
induced TNFα (Shresta et al., 2006). Attempts to similarly
ameliorate SB-induced disease in the AG129 or A129 mice by
intravenous inoculation of TNFα-neutralizing antibodies did
not significantly extend the average survival time (data not
shown).
Damage to the vasculature and plasma leakage
Extremely high levels of inflammatory mediators and
extensive hepatic replication are frequently associated with
vasculopathy and VHF in humans (Bray, 2005). To evaluate
potential hemorrhagic manifestations in TR339-infected mice,
moribund animals were intravenously injected with FITC-
conjugated BSA and extravasation of the fluorescent albuminFig. 5. Vascular leakage in tissues of TR339-infected A129 versusAG129 mice. AG1
100 pfu of TR339. At 30 h p.i. (A andB) or 60 h p.i. (C andD), corresponding to the tim
dose of FITC-BSA was delivered intravenously and allowed to circulate for 30 min
fluorescence microscopy and analyzed using ACT-1 imaging software. Multiple sectprotein into tissues was visualized by microscopy. Fluorescence
of serum samples was determined by fluorimeter to confirm
equal efficiency of FITC-BSA administration. In AG129 mice
30 h p.i., vascular leakage was observed in the lung, spleen and
particularly in the liver (Fig. 5A). In contrast, no FITC-BSAwas
detectable in infected A129 tissues 30 h p.i. (Fig. 5B), and only
moderate leakage was observed by 60 h p.i. when these animals
were moribund (Fig. 5C). No evidence of vascular leakage was
observed in infected G129 mice at any time p.i. (Fig. 5D),
indistinguishable from mock-infected mice of any genotype
(data not shown). Interestingly, no vascular leakage was
observed in the brain, even in the AG129 mice, suggestive
that the blood–brain barrier remained relatively intact. We
conclude that vascular permeability increased slightly in
moribund A129 mice, but the additional absence of IFNγ was
required to result in severe, tissue-specific vascular leakage
consistent with hemorrhagic disease.
Pathologic damage caused by TR339 virus in the absence of
IFNγ signaling
To further evaluate the vascular leakage observed in TR339-
infected AG129 mice, we performed histologic analyses of
H&E-stained tissue sections. By comparing tissues from
moribund AG129 mice (42 h p.i.) with tissues from A129
mice at the same time-point, or once these animals became
moribund (72 h p.i.), both the kinetics and process of disease
development were examined.29 (A), A129 (B and C) and G129 (D) mice were subcutaneously inoculated with
es whenAG129 or A129, respectively, exhibit clinical signs of disease, 30mg/kg
before tissue samples were collected. Cryosectioned tissues were examined by
ions from three animals were examined and representative sections are shown.
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histologically indistinguishable from mocks (data not shown),
whereas tissues from moribund A129 and AG129 mice
revealed often severe damage at the cellular and tissue levels
(Figs. 6 and 7). At 42 h p.i., infected A129 livers were virtuallyFig. 6. Liver pathology in TR339-infected A129 versus AG129 mice. Representative
(300×). TR339-infected A129 mice at (B) 42 h p.i. (300×); (C) 72 h p.i. (300×); and (
and (G) 1920×. Note the more rapid appearance of severe liver pathology in the co
increased severity of foci of confluent necrotic hepatocytes, fibrinoid defects in hepati
with E and F when both strains were moribund). Extravasation of red blood cells inindistinguishable from those of WT129 mice (Figs. 6A and B);
however, when moribund at 72 h p.i., liver sections exhibited
evidence of hepatocellular damage with fibrin deposition,
mononuclear inflammatory infiltrates and congestion of the
vasculature (Figs. 6C and D). Correlating with increased virushematoxylin and eosin (H&E)-stained liver sections. (A) Mock-infected animals
D) 72 h p.i. (600×). TR339-infected AG129 mice at 42 h p.i. (E) 300×; (F) 600×;
mbined absence of IFNα/β and IFN-γ (compare B with E at 42 h p.i.) and the
c cell plates and inflammatory infiltrates in moribund animals (compare C and D
to the parenchyma of infected AG129 liver is evident by 42 h p.i. (G).
Fig. 7. Lymphoid tissue pathology in TR339-infected A129 versus AG129 mice. Representative hematoxylin and eosin (H&E)-stained liver sections. (A) Mock-
infected animals (300×). TR339-infected A129 mice at (B) 42 h p.i. (300×); (C) 72 h p.i. (300×); and (D) 72 h p.i. (600×). TR339-infected AG129 mice at 42 h p.i. (E)
300×; and (F) 600×. Note the delayed appearance of structural disorganization and lymphocyte apoptosis in the spleens of A129 versus AG129 mice (compare B with
E at 42 h p.i., or C and D with E and F when both strains were moribund).
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more rapid disease progression, similar changes were
observed in moribund AG129 mice by 42 h p.i., advanced
approximately 30 h by the absence of IFNγ activity (Figs. 6E
and F). Furthermore, the extent and severity of pathology
exceeded that observed in moribund A129 mice and, in areas
with confluent hepatocyte necrosis, frank hemorrhage was
observed with leakage of red blood cells into the liver
parenchyma (Fig. 6G).
While we observed severe splenic damage by 72 h p.i. when
A129 mice were moribund (Figs. 7C and D), little pathological
change was evident by 42 h p.i. (Figs. 7A and B). In the spleens
of AG129 mice, dramatically decreased cellularity and
disorganization of the tissue were apparent throughout the red
and white pulp and morphological evidence of cell death was
ubiquitous (Figs. 7E and F). Pathologies observed in otherinfected tissues including involution of the thymus, inflamma-
tion in the lung and blunting of the small intestine villi also
occurred more rapidly in AG129 as compared to A129 mice and
were frequently more severe once mice became moribund (data
not shown).
These histologic findings provide evidence for severe
pathological changes in the tissues that exhibit signs of increased
vascular permeability in TR339-infected AG129 mice. Taken
together, the FITC-BSA data and histopathologic observations
support the conclusion that TR339-infected AG129 mice
manifest increased vascular permeability and hemorrhagic
manifestations consistent with development of VHF. In the
hepatic compartment, exacerbated pathology observed in
AG129 versus A129 tissues of moribund animals strongly
correlated with significant increases in viral load and dysregu-
lated, systemic release of inflammatory mediators.
Fig. 8. Elevation of transaminase enzymes in serum of TR339-infected mice.
WT129 (black square), G129 (white square), A129 (black circle) and AG129
(white circle) mice were inoculated subcutaneously with 100 pfu TR339 and
the serum was collected at various times p.i. Levels of serological markers for
cellular damage alanine transaminase (ALT) and aspartate transaminase (AST)
were determined using the Infinity AST and Infinity ALT diagnostic kits.
Values represent the mean enzymatic activity level (U/L) for three mice and
are shown±SD.
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As ameasure of tissue pathology in TR339-infected mice, we
determined the levels of aspartate aminotransferase (AST) and
alanine aminotransferase (ALT) enzymes (Fig. 8). These
enzymes are released into the circulation when cells are damaged
and consequently their levels provide an excellent non-invasive
corollary to pathology during viral infection (e.g., Kuo et al.,
1992). In both A129 and AG129 infected mice, coincident
elevation of AST and ALT was observed, increasing by
approximately 10-fold over the reference limit (mock-infected
controls) and in a roughly 1:1 ratio, which strongly suggests
severe, acute hepatocellular injury and organ dysfunction.
Interestingly, this elevation was delayed by 12 h in the presence
of IFNγ activity, consistent with the lower virus load in the liver
and extended survival of A129 versus AG129 animals.
Discussion
The importance of type I and type II IFNs in mediating innate
antiviral responses to virus infection is established by the fact
that mice lacking IFN receptors are highly susceptible to fatal
infection by a large number of viruses and that viral pathogens
have evolved an impressive array of strategies to evade or
suppress the host's non-specific antiviral responses to their own
advantage (reviewed in Basler and Garcia-Sastre, 2002; Garcia-
Sastre and Biron, 2006). SB virus, on the other hand, is part-icularly sensitive to the antiviral effects of type I IFN (Byrnes et
al., 2000; Gil et al., 2001; Ryman et al., 2000) and, in the face of
this response, the role of IFNγ in early antiviral protection has
not been considered fully.
In vitro, exogenously added IFNγ stimulates potent antiviral
activity against SB in DCs (Ryman et al., 2002) and neurons
(Burdeinick-Kerr and Griffin, 2005). Furthermore, studies in
IFNγ-deficient animals have demonstrated that this cytokine
plays a role in the non-cytopathic clearance of SB from neurons
during resolution of a non-fatal infection (Binder and Griffin,
2001; Burdeinick-Kerr et al., 2007) and provides some
protection against fatality in the absence of IFNα/β (Gil et al.,
2001). Our current findings suggest that the potential antiviral
effects of IFNγ during the acute phase of SB infection in vivo are
almost completely obscured by the dominant IFNα/β-mediated
response. Consequently, deficiency in IFNγ receptors alone did
not significantly affect the progression of TR339 infection in
G129 relative to WT129 mice, but as evidenced by comparison
to AG129 infections, endogenously induced IFNγ in infected
A129 mice was able to partially suppress or delay TR339
replication and hyperinflammatory cytokine induction, partially
ameliorate hemorrhagic disease manifestations and significantly
prolong host survival. Paradoxically, rather than exhibiting a
deficiency in induction of proinflammatory cytokines and
chemokines as might be expected based on the immunoregu-
latory properties of IFNs (e.g., Biron et al., 1998; Dalod et al.,
2002), both the A129 and AG129 mice experienced a
dysregulated cytokine response following TR339 infection.
These data suggest that the absence of IFNα/β and IFNγ did not
prevent inflammatory mediator induction, but may compromise
regulatory mechanisms or may simply be circumvented by
uncontrolled virus replication and tissue destruction. It is
interesting to note that, in addition to their well-characterized
immunoregulatory and proinflammatory activities, IFNs possess
homeostatic functions that limit inflammation and tissue
destruction in a variety of conditions (Hu et al., 2005).
A major finding of this study is the appearance of
hemorrhagic manifestations, associated with exacerbated dis-
ease progression in the combined absence of type I and type II
IFN signaling, that were significantly delayed and partially
ameliorated in the absence of IFNα/β activity in isolation.
Evidence for a VHF-like disease in TR339-infected AG129
mice included: (i) dysregulation of proinflammatory cytokine
and chemoattractant protein induction leading to sustained
elevation in serum; (ii) infiltration of inflammatory cells into the
liver, lung and intestinal parenchyma; (iii) morphological
evidence of acute hepatitis and dramatic hepatotoxicity with
coincident elevation of circulating ALT and AST enzymes; (iv)
increased vascular permeability, particularly in the liver, but also
in the thymus, spleen and lung; (v) extravasation of red blood
cells and deposition of fibrin in the parenchyma of liver and
spleen, indicating alterations in vascular function and a shift in
the coagulation system toward a procoagulant state suggestive of
disseminated intravascular coagulation (DIC); and (vi) massive
cell death in lymphoid tissues.
Current models of VHF describe systemic infection of
sentinel cells of the immune system, especially macrophages and
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signs, infected DCs and macrophages release cytokines,
chemokines and other inflammatory mediators, causing fever,
malaise and systemic inflammatory responses. Furthermore,
infection of macrophages may directly trigger the extrinsic
coagulation pathway by the induction of cell-surface tissue
factor (TF) synthesis, leading to fibrin deposition andDIC, while
infection of DCs may contribute to massive lymphocyte
apoptosis (Cobb et al., 2000). Our results are in accord with
the assumption that an important characteristic of HF viruses is
generation of high titer virus production and rapid viral
dissemination by viral suppression of type I IFN-mediated
antiviral responses (Bray, 2005). However, we now propose that
inhibition of IFNγ-mediated antiviral activities, in addition to
those of IFNα/β, may exacerbate disease and further promote
VHF development. We demonstrated previously that Küpffer
cells (resident hepatic macrophages), macrophages/DCs in the
splenic marginal zones and tissue-infiltrating CD11b+ macro-
phages become dramatically more susceptible to TR339
infection in the absence of type I IFN signaling (Ryman et al.,
2000). The further increased viral loads in these tissues resulting
from additional ablation of the IFNγ receptor shown in this
study may suggest that the liver (and possibly spleen) is a major
site of IFNγ secretion, producing an enhanced local effect. The
liver is known to be particularly enriched in NK and NKT cells
(Ahmad and Alvarez, 2004), while activated NK cells populate
the marginal zones of the spleen following virus infection
(Dokun et al., 2001) and IFNγ secretion from these cells may be
pivotal for induction of localized non-specific antiviral immu-
nity. Consistently, our preliminary data indicate that higher virus
titers in tissues such as liver of AG129 mice versus A129 mice
are associated with infection of additional cells of the
macrophage/DC lineages (unpublished data).
Low-level production of IFNα/β in the absence of virus
infection is believed to maintain a partial, pre-existing antiviral
state and predispose some cells to rapidly secrete IFNα/β upon
stimulation (Taniguchi and Takaoka, 2001), perhaps providing
immediate protection for WT129 and G129 mice upon SB
inoculation. In contrast, the synthesis and secretion of IFNγ are
coordinated by prior induction of other cytokines, most notably
IL-12 and IL-18, which are secreted by pathogen-activated
antigen presenting cells (APCs; Orange and Biron, 1996). The
primary source of IFNγ during SB infection remains to be
determined, but is speculated to be virus-infected APCs and/or
activated NK cells which function as direct antiviral effectors
during early virus infection (Orange and Biron, 1996; Tay and
Welsh, 1997).
IFNα/β and IFNγ interact with different cell-surface
receptors, but share the ability to trigger STAT1-dependent
signal transduction pathways to upregulate transcription of
ISGs. Consequently, STAT1−/− mice have increased suscept-
ibility to a number of viral infections (Durbin et al., 1996; Gil et
al., 2001; Hogan et al., 2004; Karst et al., 2003; Mumphrey et
al., 2007; Meraz et al., 1996; Shresta et al., 2005). Additionally,
both IFNα/β and IFNγ stimulate transcription of distinct
subsets of ISGs via STAT1-independent pathways (Hahm et al.,
2005; Qing and Stark, 2004; Ramana et al., 2001, 2002), andsignificant IFNα/β/γ-mediated, STAT1-independent antiviral
activity has been observed following infection with several
viruses including a cell culture-adapted SB strain (Gil et al.,
2001; Shresta et al., 2005). Here, we have shown that deficiency
in either the STAT1 protein or the IFNα/β receptor renders mice
similarly susceptible to TR339-induced disease and death, from
which we infer that both IFNα/β- and IFNγ-mediated antiviral
activities against SB are partially STAT1-independent.
In conclusion, our data demonstrate that, in the absence of
IFNα/β activity, IFNγ is able to provide compensatory anti-
viral protection during acute SB infection. Isolated ablation of
the type I IFN response renders DCs and macrophages sus-
ceptible to infection, allows high titer, systemic virus replica-
tion, results in the induction of a hyperinflammatory cytokine
cascade and leads to rapid mortality. However, when both
IFNα/β and IFNγ receptors were ablated, we observed more
severe hemorrhagic manifestations and hepatocellular injury
consistent with VHF. Thus, mice with a genetic deficiency of
IFN receptors provide a model system for systemic virus
infection and the development of VHF, enabling further
investigations of components of the immune response that
usually limit virus to localized infection. Furthermore, these
studies particularly demonstrate the importance of IFNγ for
antiviral responses and potential therapeutic intervention
against viral pathogens that have the ability to antagonize
and/or evade components of the IFNα/β system. Finally, our
findings dramatically demonstrate the importance of these non-
specific antiviral mechanisms in protection against arboviral
disease: without them even a non-pathogenic virus such as SB
causes VHF and rapid mortality of the host.
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